Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

Dizziness · people with focal epilepsy

Losigamone probably leads to higher adverse event (dizziness) compared with placebo (moderate certainty).

1 finding from 1 review

Losigamone add‐on therapy for focal epilepsy 2019 · Cochrane Headline outcomes only
RR 3.82 [1.69, 8.64]
2 studies · 467 participants
Moderate